Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02566109 · ClinicalTrials.gov registry record · NA
Community Hospital Identification of High CV Risk Patients During Cancer Treatment
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02566109: Clinical Trial NA study, sponsored by Wake Forest University Health Sciences.
NCT02566109 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02566109, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The overall of this proposal is to test in community hospitals the utility of a 10-min magnetic resonance imaging (MRI) scan protocol combined with proprietary image analysis algorithms for detecting early cardiovascular (CV) injury during receipt of chemotherapy for breast cancer (BrC) and lymphoma. This technology provides health-care delivery systems with a time-efficient method to identify those at risk of a future CV event so that prevention can be implemented to prolong survival and reduce morbidity in cancer survivors.
Primary Outcome
To compare baseline, 2-month (using Fast MRI), and 6 month measures in left ventricular (LV) ejection fraction
Interventions
- DIAGNOSTIC_TEST Fast MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-02-25 |
| Est. Completion | 2017-10-04 |
| Phase | NA |
Why NCT02566109 stopped before completion
NCT02566109 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Fast MRI is the first listed.
NCT02566109 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02566109 about?
NCT02566109 is a clinical study titled "Community Hospital Identification of High CV Risk Patients During Cancer Treatment". The overall of this proposal is to test in community hospitals the utility of a 10-min magnetic resonance imaging (MRI) scan protocol combined with proprietary image analysis algorithms for detecting early cardiovascular (CV) injury during receipt of chemotherapy for breast cancer (BrC) and lymphoma...
What is the current status of trial NCT02566109?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2016-02-25. Estimated completion is 2017-10-04.
What interventions are being tested in trial NCT02566109?
The interventions under investigation include: Fast MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02566109?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02566109's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI